Bihui Cao
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Immunology top 10%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
Papers in
- Oncology 10
- CAR-T cell therapy research 9
- Cancer Immunotherapy and Biomarkers 2
-
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 4
- Co-authors
- Kangshun Zhu (6 shared papers)Shuo Yang (5 shared papers)Baoxia Liang (4 shared papers)Jingwen Zhou (4 shared papers)Wensou Huang (4 shared papers)Mingyue Cai (4 shared papers)Qi Zhao (6 shared papers)Yongjian Guo (4 shared papers)
- Journals
- International Journal of Biological Sciences (2 papers)Bioactive Materials (1 paper)Journal of Hematology & Oncology (1 paper)Biochemical and Biophysical Research Communications (1 paper)JCI Insight (1 paper)
- Partner nations
- ChinaUnited StatesMacao
In The Last Decade
Bihui Cao
19 papers receiving 587 citations
Bihui Cao's Hit Papers
Peers
Comparison fields: 5 of 57
- Hepatology 126
- Immunology 221
- Oncology 248
- Cancer Research 54
- Pulmonary and Respiratory Medicine 89
Countries citing papers authored by Bihui Cao
This map shows the geographic impact of Bihui Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bihui Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bihui Cao more than expected).
Fields of papers citing papers by Bihui Cao
This network shows the impact of papers produced by Bihui Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bihui Cao. The network helps show where Bihui Cao may publish in the future.
Co-authors
The 25 scholars most cited alongside Bihui Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Transarterial Chemoembolization Combined With Lenvatinib Plus PD-1 Inhibitor for Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study Hit paper breakdown → | 2022 | 128 |
| 2 | 2021 | 82 | |
| 3 | 2021 | 76 | |
| 4 | 2021 | 76 | |
| 5 | 2020 | 75 | |
| 6 | 2020 | 58 | |
| 7 | 2024 | 22 | |
| 8 | 2024 | 14 | |
| 9 | 2024 | 12 | |
| 10 | 2024 | 12 | |
| 11 | 2021 | 9 | |
| 12 | 2024 | 9 | |
| 13 | 2025 | 6 | |
| 14 | 2017 | 4 | |
| 15 | 2023 | 4 | |
| 16 | 2025 | 3 | |
| 17 | 2023 | 3 | |
| 18 | 2019 | 1 | |
| 19 | 2025 | 1 | |
| 20 | 2025 | 0 |
About Bihui Cao
Bihui Cao is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Hepatology, having authored 21 papers that have together received 595 indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), DNA Repair Mechanisms (1 paper), Ferroptosis and cancer prognosis (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Hepatology (126 citations), Immunology (221 citations), Oncology (248 citations), Cancer Research (54 citations) and Pulmonary and Respiratory Medicine (89 citations). Bihui Cao has collaborated with scholars based in China, United States and Macao. Frequent co-authors include Kangshun Zhu, Shuo Yang, Baoxia Liang, Jingwen Zhou, Wensou Huang, Mingyue Cai, Qi Zhao, Yongjian Guo, Licong Liang and Liteng Lin. Their work appears in journals such as International Journal of Biological Sciences, Bioactive Materials, Journal of Hematology & Oncology, Biochemical and Biophysical Research Communications and JCI Insight.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.